Cardiac arrhythmias in the intensive care unit

Seminars in Respiratory and Critical Care Medicine

Volumn 27, Issue 3, 2006, Pages 221-229

  Tarditi, Daniel J ^a   Hollenberg, Steven M ^a  

^a Department of Anesthesiology   (United States)

Author keywords

Arrhythmia; Atrial fibrillation; Atrial flutter; AV nodal reentrant tachycardia; Bradycardia; Electrical storm; ICU; Sinus tachycardia; Ventricular tachycardia; Wolff Parkinson White syndrome

Indexed keywords

ADENOSINE; AMIODARONE; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIGOXIN; DILTIAZEM; ESMOLOL; FLECAINIDE; HEPARIN; LIDOCAINE; MAGNESIUM; METOPROLOL; MORACIZINE; PROCAINAMIDE; PROPAFENONE; PROPRANOLOL; VERAPAMIL;

ANTICOAGULANT THERAPY; ATRIOVENTRICULAR JUNCTION ARRHYTHMIA; BRADYCARDIA; CARDIOVERSION; CATECHOLAMINE BLOOD LEVEL; ELECTRICAL STORM; ELECTROLYTE DISTURBANCE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART ATRIUM FLUTTER; HEART DISEASE; HEART MUSCLE ISCHEMIA; HEART VENTRICLE TACHYCARDIA; HUMAN; HYPOXIA; INFECTION; INTENSIVE CARE UNIT; MORBIDITY; PRIORITY JOURNAL; REENTRY TACHYCARDIA; REVIEW; SINUS TACHYCARDIA; SUDDEN DEATH; WOLFF PARKINSON WHITE SYNDROME;

ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIA; ARRHYTHMIAS, CARDIAC; ATRIAL FIBRILLATION; ATRIAL FLUTTER; BRADYCARDIA; DEFIBRILLATORS, IMPLANTABLE; ELECTROCARDIOGRAPHY; EVALUATION STUDIES; EVALUATION STUDIES AS TOPIC; HUMANS; INTENSIVE CARE UNITS; PACEMAKER, ARTIFICIAL; TACHYCARDIA, ATRIOVENTRICULAR NODAL REENTRY; TACHYCARDIA, SINUS; TACHYCARDIA, VENTRICULAR; TORSADES DE POINTES; WOLFF-PARKINSON-WHITE SYNDROME;

EID: 33745956777     PISSN: 10693424     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-945525     Document Type: Review

References (56)

1. Imrie JR, Yee R, Klein GJ, Sharma AD. Incidence and clinical significance of ST segment depression in supraventricular tachycardia. Can J Cardiol 1990;6:323-326
2. Tebbenjohanns J, Pfeiffer D, Schumacher B, Jung W, Manz M, Luderitz B. Intravenous adenosine during atrioventricular reentrant tachycardia: induction of atrial fibrillation with rapid conduction over an accessory pathway. Pacing Clin Electrophysiol 1995;18:743-746
3. Pelleg A, Pennock RS, Kutalek SP. Proarrhythmic effects of adenosine: one decade of clinical data. Am J Ther 2002;9:141-147
4. Winniford MD, Fulton KL, Hillis LD. Long-term therapy of paroxysmal supraventricular tachycardia: a randomized, double-blind comparison of digoxin, propranolol and verapamil. Am J Cardiol 1984;54:1138-1139
5. Lown B. Electrical reversion of cardiac arrhythmias. Br Heart J 1967;29;469-489
6. Ellenbogen KA, Stambler BS, Wood MA, et al. Efficacy of intravenous ibutilide for rapid termination of atrial fibrillation and atrial flutter: a dose-response study. J Am Coll Cardiol 1996;28:130-136
7. Stambler BS, Wood MA, Ellenbogen KA, Perry KT, Wakefield LK, VanderLugt JT. Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Ibutilide Repeat Dose Study Investigators. Circulation 1996;94:1613-1621
8. Sung RJ, Tan HL, Karagounis L, et al. Intravenous sotalol for the termination of supraventricular tachycardia and atrial fibrillation and flutter: a multicenter, randomized, double-blind, placebo-controlled study. Sotalol Multicenter Study Group. Am Heart J 1995;129:739-748
9. Kingma JH, Suttorp MJ. Acute pharmacologic conversion of atrial fibrillation and flutter: the role of flecainide, propafenone, and verapamil. Am J Cardiol 1992;70;56A-60A discussion A-1A
10. Suttorp MJ, Kingma JH, Jessurun ER, Lie AHL, van Hemel NM, Lie KI. The value of class IC antiarrhythmic drugs for acute conversion of paroxysmal atrial fibrillation or flutter to sinus rhythm. J Am Coll Cardiol 1990;16:1722-1727
11. Trappe HJ, Brandts B, Weismueller P. Arrhythmias in the intensive care patient. Curr Opin Crit Care 2003;9:345-355
12. Feinberg WM, Blackshear JL, Laupacis A, Kronmal R, Hart RG. Prevalence, age distribution, and gender of patients with atrial fibrillation: analysis and implications. Arch Intern Med 1995;155:469-473
13. Kannel WB, Abbott RD, Savage DD, McNamara PM. Epidemiologic features of chronic atrial fibrillation: the Framingham study. N Engl J Med 1982;306:1018-1022
14. Davidson E, Weinberger I, Rotenberg Z, Fuchs J, Agmon J. Atrial fibrillation: cause and time of onset. Arch Intern Med 1989;149:457-459
15. Koh KK, Song JH, Kwon KS, et al. Comparative study of efficacy and safety of low-dose diltiazem or betaxolol in combination with digoxin to control ventricular rate in chronic atrial fibrillation: randomized crossover study. Int J Cardiol 1995;52:167-174
16. Phillips BG, Gandhi AJ, Sanoski CA, Just VL, Bauman JL. Comparison of intravenous diltiazem and verapamil for the acute treatment of atrial fibrillation and atrial flutter. Pharmacotherapy 1997;17:1238-1245
17. Ellenbogen KA, Dias VC, Plumb VJ, Heywood JT, Mirvis DM. A placebo-controlled trial of continuous intravenous diltiazem infusion for 24-hour heart rate control during atrial fibrillation and atrial flutter: a multicenter study. J Am Coll Cardiol 1991;18:891-897
18. Jordaens L, Trouerbach J, Calle P, et al. Conversion of atrial fibrillation to sinus rhythm and rate control by digoxin in comparison to placebo. Eur Heart J 1997;18:643-648
19. Arnold AZ, Mick MJ, Mazurek RP, Loop FD, Trohman RG. Role of prophylactic anticoagulation for direct current cardioversion in patients with atrial fibrillation or atrial flutter. J Am Coll Cardiol 1992;19:851-855
20. Bjerkelund CJ, Orning OM. The efficacy of anticoagulant therapy in preventing embolism related to D.C. electrical conversion of atrial fibrillation. Am J Cardiol 1969;23:208-216
21. Ommen SR, Odell JA, Stanton MS. Atrial arrhythmias after cardiothoracic surgery. N Engl J Med 1997;336:1429-1434
22. Hashimoto K, Ilstrup DM, Schaff HV. Influence of clinical and hemodynamic variables on risk of supraventricular tachycardia after coronary artery bypass. J Thorac Cardiovasc Surg 1991;101:56-65
23. Crystal E, Connolly SJ, Sleik K, Ginger TJ, Yusuf S. Interventions on prevention of postoperative atrial fibrillation in patients undergoing heart surgery: a meta-analysis. Circulation 2002;106:75-80
24. Stebbins D, Igidbashian L, Goldman SM, et al: Clinical outcome of patients who develop atrial fibrillation after coronary artery bypass surgery [abstract]. PACE 1995;18:798
25. Gage BF, Waterman AD, Shannon W, Boechler M, Rich MW, Radford MJ. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA 2001;285:2864-2870
26. Wang K, Goldfarb BL, Gobel FL, Richman HG. Multifocal atrial tachycardia. Arch Intern Med 1977;137:161-164
27. Wagner G. Marriott's Practical Electrocardiography. Philadelphia, PA: Lippincott Williams and Wilkins; 2001
28. Shenasa M, Borggrefe M, Haverkamp W, Hindricks G, Breithardt G. Ventricular tachycardia. Lancet 1993;341: 1512-1519
29. Wellens HJ, Brugada P. Diagnosis of ventricular tachycardia from the 12-lead electrocardiogram. Cardiol Clin 1987;5; 511-525
30. Josephson ME, Wellens HJ. Differential diagnosis of supraventricular tachycardia. Cardiol Clin 1990;8:411-442
31. Wellens HJ, Bar FW, Lie KI. The value of the electrocardiogram in the differential diagnosis of a tachycardia with a widened QRS complex. Am J Med 1978;64:27-33
32. Brugada P, Brugada J, Mont L, Smeets J, Andries EW. A new approach to the differential diagnosis of a regular tachycardia with a wide QRS complex. Circulation 1991;83:1649-1659
33. Tchou P, Young P, Mahmud R, Denker S, Jazayeri M, Akhtar M. Useful clinical criteria for the diagnosis of ventricular tachycardia. Am J Med 1988;84:53-56
34. Kostis JB, McCrone K, Moreyra AE, et al. Premature ventricular complexes in the absence of identifiable heart disease. Circulation 1981;63:1351-1356
35. Raftery EB, Cashman PM. Long-term recording of the electrocardiogram in a normal population. Postgrad Med J 1976;52(Suppl 7):32-38
36. Fleg JL, Kennedy HL. Cardiac arrhythmias in a healthy elderly population: detection by 24-hour ambulatory electrocardiography. Chest 1982;81:302-307
37. Anderson KP, DeCamilla J, Moss AJ. Clinical significance of ventricular tachycardia (3 beats or longer) detected during ambulatory monitoring after myocardial infarction. Circulation 1978;57:890-897
38. Buxton AE, Marchlinski FE, Waxman HL, Flores BT, Cassidy DM, Josephson ME. Prognostic factors in non-sustained ventricular tachycardia. Am J Cardiol 1984;53:1275-1279
39. Larsen L, Markham J, Haffajee CI. Sudden death in idiopathic dilated cardiomyopathy: role of ventricular arrhythmias. Pacing Clin Electrophysiol 1993;16:1051-1059
40. Gregoratos G, Abrams J, Epstein AE, et al. ACC/AHA/NASPE 2002 guideline update for implantation of cardiac pacemakers and antiarrhythmia devices: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/NASPE Committee to Update the 1998 Pacemaker Guidelines). Circulation 2002;106:2145-2161
41. Kligfield P, Levy D, Devereux RB, Savage DD. Arrhythmias and sudden death in mitral valve prolapse. Am Heart J 1987; 113:1298-1307
42. Kligfield P, Hochreiter C, Niles N, Devereux RB, Borer JS. Relation of sudden death in pure mitral regurgitation, with and without mitral valve prolapse, to repetitive ventricular arrhythmias and right and left ventricular ejection fractions. Am J Cardiol 1987;60:397-399
43. Wolfe RR, Driscoll DJ, Gersony WM, et al. Arrhythmias in patients with valvar aortic stenosis, valvar pulmonary stenosis, and ventricular septal defect: results of 24-hour ECG monitoring. Circulation 1993;87:I89-101
44. Newby KH, Thompson T, Stebbins A, Topol EJ, Califf RM, Natale A. Sustained ventricular arrhythmias in patients receiving thrombolytic therapy: incidence and outcomes. The GUSTO Investigators. Circulation 1998;98:2567-2573
45. Trujillo TC, Nolan PE. Antiarrhythmic agents: drug interactions of clinical significance. Drug Saf 2000;23:509-532
46. Kossmann CE. Torsade de pointes: an addition to the nosography of ventricular tachycardia. Am J Cardiol 1978;42: 1054-1056
47. Banai S, Tzivoni D. Drug therapy for torsade de pointes. J Cardiovasc Electrophysiol 1993;4:206-210
48. Campbell RW, Smith RA, Gallagher JJ, Pritchett EL, Wallace AG. Atrial fibrillation in the preexcitation syndrome. Am J Cardiol 1977;40:514-520
49. Exner DV, Pinski SL, Wyse DG, et al. Electrical storm presages nonsudden death: the antiarrhythmics versus implantable defibrillators (AVID) trial. Circulation 2001;103: 2066-2071
50. Greene M, Geist M, Paquette M, et al. Long-term follow-up of implantable defibrillator therapy in patients with electrical storm [abstract]. Pacing Clin Electrophysiol 1997;20:1207
51. O'Donoghue S, Patia EV, Waclawski S, et al. Transient electrical storm: prognostic significance of very numerous automatic defibrillator discharges [abstract]. J Am Coll Cardiol 1997;17:352A
52. Passman R, Kadish A. Polymorphic ventricular tachycardia, long Q-T syndrome, and torsades de pointes. Med Clin North Am 2001;85:321-341
53. Tschaidse O, Graboys TB, Lown B, Lampert S, Ravid S. The prevalence of proarrhythmic events during moricizine therapy and their relationship to ventricular function. Am Heart J 1992;124:912-916
54. Kowey PR. An overview of antiarrhythmic drug management of electrical storm. Can J Cardiol 1996;12(Suppl B):3B-8B; discussion 27B-28B
55. Brugada J, Berruezo A, Cuesta A, et al. Nonsurgical transthoracic epicardial radiofrequency ablation: an alternative in incessant ventricular tachycardia. J Am Coll Cardiol 2003; 41:2036-2043
56. Gregoratos G, Cheitlin MD, Conill A, et al. ACC/AHA guidelines for implantation of cardiac pacemakers and antiarrhythmia devices: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Pacemaker Implantation). J Am Coll Cardiol 1998;31:1175-1209